<DOC>
	<DOCNO>NCT02747550</DOCNO>
	<brief_summary>The aim study evaluate efficacy safety temporary simultaneous two-arterial occlusion ( TESTO ) operative blood loss laparoscopic myomectomy .</brief_summary>
	<brief_title>Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy</brief_title>
	<detailed_description>Significant hemorrhage major perioperative concern myomectomy , result need blood transfusion , conversion hysterectomy , development hypovolemic shock postoperative anemia , delayed recovery . Therefore , method decrease operative blood loss myomectomy woman wish preserve uterus fertility important must develop .</detailed_description>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<criteria>woman symptomatic myoma menorrhagia , pelvic pressure/pain , infertility woman plan undergo laparoscopic myomectomy woman ≤ 4 myoma , large myoma ≤ 10 cm woman regular menstrual bleeding ( defined cycle length 21 45 day ) woman pregnant surgery woman 19 45 year age . woman underwent concomitant complex surgical procedure time laparoscopic myomectomy , severe adhesiolysis resection severe endometriosis woman postmenopausal climacteric status woman history oophorectomy salpingooophorectomy woman suggestion malignant uterine adnexal disease woman major medical comorbidities psychiatric illness , could affect followup and/or compliance woman refuse participate give consent procedure</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>